The increasing utilization of these immune checkpoint inhibitors has presented new of immune-related adverse events that have proven to be extremely challenging to manage.
Tyler Beardslee, PharmD, BCOP
Advertisement
Articles by Tyler Beardslee, PharmD, BCOP
Advertisement
Latest Updated Articles
Management of Steroid-Refractory Immune-Related Adverse EventsAugust 23rd 2019
Advertisement
Advertisement
Trending on CancerNetwork
1
Low-Dose CT Screening Reduces Lung Cancer–Specific Mortality
2
FDA Approves Companion Diagnostic for Pembrolizumab in Esophageal/GEJ Carcinoma
3
Durvalumab/SBRT May Limit Tumor Progression in Early-Stage NSCLC
4
Frontline IO-Combos, Next-Generation ADCs: Evolutions in Endometrial Cancer
5